Correlation Between Edgewise Therapeutics and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Verona Pharma PLC, you can compare the effects of market volatilities on Edgewise Therapeutics and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Verona Pharma.
Diversification Opportunities for Edgewise Therapeutics and Verona Pharma
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Edgewise and Verona is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Verona Pharma go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Verona Pharma
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Verona Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.43 times less risky than Verona Pharma. The stock trades about -0.11 of its potential returns per unit of risk. The Verona Pharma PLC is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 3,311 in Verona Pharma PLC on August 28, 2024 and sell it today you would earn a total of 657.00 from holding Verona Pharma PLC or generate 19.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Verona Pharma PLC
Performance |
| Timeline |
| Edgewise Therapeutics |
| Verona Pharma PLC |
Edgewise Therapeutics and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Verona Pharma
The main advantage of trading using opposite Edgewise Therapeutics and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |